BC
CRL icon

Brinker Capital’s Charles River Laboratories CRL Stock Holding History

Brinker Capital’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$723K Buy
+4,148
New +$662K 0.02% 601
2020
Q1 		– Sell
-1,658
Closed -$253K – 922
2019
Q4 		$253K Sell
1,658
-279
-14% -$38.6K 0.01% 876
2019
Q3 		$256K Sell
1,937
-187
-9% -$25.1K 0.01% 858
2019
Q2 		$301K Sell
2,124
-110
-5% -$14.9K 0.01% 820
2019
Q1 		$324K Sell
2,234
-116
-5% -$15.2K 0.01% 792
2018
Q4 		$266K Sell
2,350
-126
-5% -$15.8K 0.01% 764
2018
Q3 		$333K Sell
2,476
-112
-4% -$13.8K 0.01% 829
2018
Q2 		$291K Sell
2,588
-825
-24% -$89.2K 0.01% 869
2018
Q1 		$364K Sell
3,413
-1,842
-35% -$199K 0.01% 810
2017
Q4 		$575K Buy
5,255
+19
+0.4% +$2.07K 0.02% 645
2017
Q3 		$566K Buy
+5,236
New +$538K 0.02% 624
2017
Q2 		– Sell
-3,541
Closed -$319K – 698
2017
Q1 		$319K Sell
3,541
-143
-4% -$12.1K 0.01% 766
2016
Q4 		$281K Buy
+3,684
New +$280K 0.02% 597

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Brinker Capital's CRL Position: Q2 2020 in Review

Brinker Capital opened a new position in Charles River Laboratories (CRL) in Q2 2020: 4,148 shares worth $723K. The stake represents 0.02% of the portfolio and ranks #601 among its holdings. This is a return to the name: Brinker Capital previously reported a position in CRL as recently as Q4 2019.

Brinker Capital first reported a position in CRL in Q4 2016 and has held it in 13 quarters since. 466 funds tracked by Wall St. Rank hold CRL as of Q2 2020.

  • Brinker Capital held 4,148 shares of Charles River Laboratories worth $723K as of Q2 2020.
  • Charles River Laboratories was a new Brinker Capital position in Q2 2020.
  • Charles River Laboratories made up 0.02% of Brinker Capital's portfolio in Q2 2020, its #601 holding.
  • Brinker Capital first reported a position in Charles River Laboratories in Q4 2016 and has held it in 13 quarters since.
  • 466 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.